Literature DB >> 10720076

Presence of a 5-HT7 receptor positively coupled to adenylate cyclase activation in human granulosa-lutein cells.

C Graveleau1, H J Paust, D Schmidt-Grimminger, A K Mukhopadhyay.   

Abstract

Although serotonin (5-HT) has been shown to stimulate progesterone production by human granulosa-lutein cells (hGLC), the receptor type and associated signaling pathway remain uncharacterized. We report here that 5-HT receptors in these cells are positively coupled to adenylate cyclase activity. Formation of cAMP was stimulated by 5-HT and its agonists in a dose- and time-dependent manner. Mianserin, amoxapine, and loxapine were equipotent in antagonizing 5-HT-induced cAMP formation. For both cAMP formation in cells and adenylate cyclase assay using membrane fractions, the rank order of potency for agonists of 5-HT were: 5-carboxy-aminotryptamine >5-HT> or =5-methoxytryptamine, consistent with a typical pharmacological profile of human 5-ht7 (h5-ht7) receptor. Sequence data of amplified complementary DNA fragments reverse transcribed from hGLC RNA revealed complete identity with published sequence of h5-ht7 receptor complementary DNA. Northern analysis showed the presence of 2.8-kb h5-ht7 transcripts in hGLC. The three variants h5-ht7A, h5-ht7B, and h5-ht7D were also detected in hGLC. Preincubation of hGLC with 5-HT (10(-8)-10(-6) M) resulted in a marked reduction in the cAMP response when the cells were subsequently stimulated with gonadotropin, and this heterologous desensitization could be reversed by 5-ht7 receptor antagonist clozapine. These data demonstrate that h5-ht7 receptor is present and stimulate cAMP formation in hGLC. In addition, the h5-ht7 receptor seems to be implicated in the heterologous down-regulation hCG-stimulated cAMP response in hGLC, with a possible ramification for luteal insufficiency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720076     DOI: 10.1210/jcem.85.3.6448

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

Review 2.  The 5-HT(7) receptor in learning and memory.

Authors:  Amanda J Roberts; Peter B Hedlund
Journal:  Hippocampus       Date:  2011-04-11       Impact factor: 3.899

3.  Synthesis and Membrane Transport of Serotonin in the Developing Ovarian Follicle of Mouse.

Authors:  D A Nikishin; N M Alyoshina; Y B Shmukler
Journal:  Dokl Biochem Biophys       Date:  2018-03-14       Impact factor: 0.788

4.  Illicit Upregulation of Serotonin Signaling Pathway in Adrenals of Patients With High Plasma or Intra-Adrenal ACTH Levels.

Authors:  Julie Le Mestre; Céline Duparc; Yves Reznik; Fidéline Bonnet-Serrano; Philippe Touraine; Olivier Chabre; Jacques Young; Mari Suzuki; Mathilde Sibony; Françoise Gobet; Constantine A Stratakis; Gérald Raverot; Jérôme Bertherat; Hervé Lefebvre; Estelle Louiset
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

5.  Serotonin may alter the pattern of gonadotropin-induced progesterone release of human granulosa cells in superfusion system.

Authors:  Miklos Koppan; Jozsef Bodis; Zsofia Verzar; Hans-Rudolf Tinneberg; Attila Torok
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

Review 6.  The 5-HT7 receptor and disorders of the nervous system: an overview.

Authors:  Peter B Hedlund
Journal:  Psychopharmacology (Berl)       Date:  2009-08-01       Impact factor: 4.530

Review 7.  Cell-to-cell communication in bilateral macronodular adrenal hyperplasia causing hypercortisolism.

Authors:  Hervé Lefebvre; Céline Duparc; Gaëtan Prévost; Jérôme Bertherat; Estelle Louiset
Journal:  Front Endocrinol (Lausanne)       Date:  2015-04-20       Impact factor: 5.555

8.  Salts of Amoxapine with Improved Solubility for Enhanced Pharmaceutical Applicability.

Authors:  Mayank Joshi; Angshuman Roy Choudhury
Journal:  ACS Omega       Date:  2018-02-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.